Excimer LASER coronary atherectomy for ST-segment elevation myocardial infarction: Insights from a multicenter...

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Coronary Syndromes

Background:

• Excimer laser coronary atherectomy (ELCA) is utilized for thrombotic lesions in ST-segment elevation myocardial infarction (STEMI).
• The clinical effectiveness of ELCA in STEMI patients remains incompletely understood.

Purpose of the Study:

• To evaluate the effectiveness of ELCA in patients with STEMI undergoing primary percutaneous coronary intervention.
• To compare clinical outcomes between patients treated with and without ELCA.

Main Methods:

• Retrospective analysis of consecutive STEMI patients within 24 hours of symptom onset.
• Patients were divided into ELCA and non-ELCA groups.
• Target vessel-related major adverse cardiac events (TV-MACE) were the primary endpoint, analyzed using Cox regression and propensity score matching.

Main Results:

• No significant difference in TV-MACE-free survival between ELCA and non-ELCA groups in the overall cohort (2593 patients).
• ELCA use was not a significant predictor of TV-MACE (HR 1.265, p=0.161).
• In propensity score-matched cohort (736 patients), TV-MACE-free survival remained similar between groups.

Conclusions:

• ELCA use is not associated with reduced adverse cardiac events in STEMI patients.
• A trend towards better outcomes was observed with large-sized ELCA catheters (1.4-1.7 mm), suggesting potential benefits.
• Further prospective studies are warranted to confirm the efficacy of large-sized ELCA catheters in STEMI.